Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trial
2 September 2024 (14:03 - 14:22)
Organised by: 
About the speaker
University Medical Centre Groningen, Groningen (Netherlands (The))
3 More presentations in this session
Professor J. Camm (London, GB)
Access the full session
The Event
ESC Congress 2024
2 September 2024
14:03 CET
You may be interested in
Congress Session
Congress Presentation
Congress Presentation
